Fin d'année 31 Mars 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Return on Assets (%) | -7.464 | -6.661 |
Return on Equity (%) | -22.042 | -25.225 |
Return on Invested Capital (%) | -2.056 | -10.545 |
Operating Margin (%) | -1.341 | -2.657 |
Net Profit Margin (%) | -2.276 | -3.668 |
Book Value Per Share | 0.309 | 0.248 |
Earnings Per Share | -0.038 | -0.078 |
Cash Per Share | 0.158 | 0.279 |
Working Capital Per Share | 0.196 | 0.09 |
Operating Profit Per Share | 0.318 | 0.335 |
EBIT Per Share | -0.034 | -0.079 |
EBITDA Per Share | -0.034 | -0.079 |
Free Cash Flow Per Share | 0.041 | -0.016 |
Fin d'année 31 Mars 2023 | 2022 | 2023 |
---|---|---|
Current Ratio | 1.511 | 1.119 |
Quick Ratio | 1.369 | 0.996 |
Inventory Turnover (Days) | 0.965 | 0.746 |
Actions en circulation | 32,5M | 32,5M |
Fin d'année 31 Mars 2023 | ||
---|---|---|
USD (US$) | USD (US$) | |
Actions en circulation | N/A | |
Return on Assets (%) | N/A | |
Return on Equity (%) | N/A | |
Return on Invested Capital (%) | N/A | |
Operating Margin (%) | N/A | |
Net Profit Margin (%) | N/A | |
Sales Per Share | N/A | |
Book Value Per Share | N/A | |
Earnings Per Share | N/A | |
Cash Per Share | N/A | |
Working Capital Per Share | N/A | |
Operating Profit Per Share | N/A | |
EBIT Per Share | N/A | |
EBITDA Per Share | N/A | |
Free Cash Flow Per Share | N/A | |
Current Ratio | N/A | |
Quick Ratio | N/A | |
Inventory Turnover (Days) | N/A |
Capitalisation boursière | 22,75M |
Ratio cours/bénéfice | -8,99 |
Ratio prix/ventes | 0,33 |
Ratio prix/liquidités | 2,51 |
Ratio prix/valeur comptable | 2,58 |
Rendement de dividende | - |
Actions en circulation | 35,55M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales